Sunday, 15 November 2026European Markets

DSM KON And AIR LIQUIDE Have A High Dividend Yield And Return On Equity In The Specialty Chemicals Industry.

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Loading stream...

(vianews) - dsm kon (dsm.as) is among this list of stock assets with the highest dividend rate and return on equity on the specialty chemicals industry.

financial asset price forward dividend yield return on equity
dsm kon (dsm.as) €115.00 2.29% 4.69%
air liquide (ai.pa) €163.84 1.83% 12.77%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. dsm kon (dsm.as)

2.29% forward dividend yield and 4.69% return on equity

koninklijke dsm n.v., a science-based company, engages in health and nutrition businesses in the netherlands, switzerland, rest of europe, north america, latin america, china, rest of asia, and internationally. it operates through animal nutrition & health (anh); health, nutrition & care (hnc); and food & beverage segments. the animal nutrition & health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. the health, nutrition & care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. it offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. the food & beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory foods; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. the company was founded in 1902 and is headquartered in heerlen, the netherlands.

earnings per share

as for profitability, dsm kon has a trailing twelve months eps of €6.25.

pe ratio

dsm kon has a trailing twelve months price to earnings ratio of 18.4. meaning, the purchaser of the share is investing €18.4 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.69%.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on aug 4, 2022, the estimated forward annual dividend rate is 2.63 and the estimated forward annual dividend yield is 2.29%.

sales growth

dsm kon's sales growth is 46.8% for the current quarter and 13.9% for the next.

more news about dsm kon.

2. air liquide (ai.pa)

1.83% forward dividend yield and 12.77% return on equity

l'air liquide s.a. provides gases, technologies, and services for the industrial and health sectors in europe, the americas, the asia pacific, the middle east, and africa. the gas & services segment comprises large industries business, which offers gas and energy solutions including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, as well as operates cogeneration plants to supply steam and electricity to metals, chemicals, refining, and energy industries; and industrial merchant business line provides industrial gases, equipment, hardgoods, and associated services to material and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sector. this segment also includes healthcare business, which provides medical gases, home healthcare services, medical equipment, and specialty ingredient to patients, healthcare professionals, and hospitals; and electronic business supply carrier gases, electronic specialty and advanced materials, equipment and installation, and service to semiconductor, flat panel, and photovoltaic markets. its engineering & construction segment designs, develops, and builds industrial gas production plants to third parties; and design and manufacture plants in traditional, renewable and alternative energy sectors. the global markets & technologies segment delivers technological solutions, such as molecules, equipment, and services to energy transition, primarily in transport, energy, and waste valorization, as well as space exploration, aerospace, fundamental sciences, and quantum computing. this segment also invests in biomethane production units; develops stations for distributing natural biogas for vehicles and hydrogen; operates biomethane production units for maritime industry; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. l'air liquide s.a. was incorporated in 1902 and is headquartered in paris, france.

earnings per share

as for profitability, air liquide has a trailing twelve months eps of €5.28.

pe ratio

air liquide has a trailing twelve months price to earnings ratio of 31.03. meaning, the purchaser of the share is investing €31.03 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.77%.

volatility

air liquide's last week, last month's, and last quarter's current intraday variation average was 0.04%, 0.20%, and 0.89%.

air liquide's highest amplitude of average volatility was 0.43% (last week), 0.51% (last month), and 0.89% (last quarter).

yearly top and bottom value

air liquide's stock is valued at €163.84 at 17:40 est, higher than its 52-week high of €153.40.

more news about air liquide.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com